Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis. Takagi S, Sasaki Y, Koike S, Takemoto A, et al. Oncogene 2021;40:5548-5558.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Takagi S, Sasaki Y, Koike S, Takemoto A, et al. Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis. Oncogene 2021;40:5548-5558.
PMID: 34302117